Innate Pharma annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Innate Pharma Revenue Growth & History (IPH)
Innate Pharma reported €9.0M in revenue for fiscal 2025, a decrease of 55.25% from the previous fiscal year.
View full Innate Pharma company overviewInnate Pharma annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €9.0M | −€11.1M | −55.25% |
| 2024 | 2024-12-31 | €20.1M | −€41.5M | −67.36% |
| 2023 | 2023-12-31 | €61.6M | €4.0M | +6.88% |
| 2022 | 2022-12-31 | €57.7M | €33.0M | +133.47% |
| 2021 | 2021-12-31 | €24.7M | −€45.1M | −64.60% |
| 2020 | 2020-12-31 | €69.8M | −€16.0M | −18.69% |
| 2019 | 2019-12-31 | €85.8M | −€8.1M | −8.66% |
| 2018 | 2018-12-31 | €94.0M | €49.9M | +113.37% |
| 2017 | 2017-12-31 | €44.0M | — | — |
Innate Pharma revenue growth trends
Over the last five reported fiscal years, revenue declined from €69.8M to €9.0M, a compound annual decline of 33.60%.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Innate Pharma source filings ↗